Related Experiment Videos
Technique and experience with azygos patch modified Blalock-Taussig anastomosis for congenital cyanotic heart disease
Insights
This modified Blalock-Taussig shunt using an azygos vein patch offers a safe and effective palliative option for complex congenital cyanotic heart disease in infants, with no early deaths or shunt failures.
Area of Science:
- Pediatric Cardiac Surgery
- Congenital Heart Disease
- Vascular Anastomosis Techniques
Background:
- Congenital cyanotic heart disease often requires palliative surgical interventions in infants.
- The standard Blalock-Taussig shunt has limitations in complex cases.
- Early correction is not always feasible for complex congenital heart defects.
Purpose of the Study:
- To evaluate the safety and efficacy of a modified Blalock-Taussig shunt using an azygos vein patch in infants with congenital cyanotic heart disease.
- To assess the long-term outcomes of this surgical modification.
Main Methods:
- Seventeen infants (1 day to 28 months) with complex congenital cyanotic heart disease underwent the modified Blalock-Taussig shunt.
- The modification involves mobilizing the subclavian artery and using an autologous azygos vein patch.
- Technique focuses on creating a tension-free shunt and avoiding pulmonary overcirculation.
Main Results:
- No early deaths or shunt failures were observed in the 17 patients.
- Postoperative complications included prolonged intubation (2 patients) and wound infection (1 patient).
- Follow-up showed minimal cyanosis, stable hemoglobin, good shunt murmurs, and no upper extremity complications; 2 late deaths occurred.
Conclusions:
- The azygos vein patch modified Blalock-Taussig shunt is a safe and effective palliative procedure for complex congenital cyanotic heart disease in infants.
- This technique provides a tension-free anastomosis and avoids pulmonary overcirculation.
- The modification demonstrates favorable short- and long-term outcomes in this challenging patient population.
Abstract:
Seventeen patients 1 day to 28 months old with congenital cyanotic heart disease underwent a modification of the Blalock-Taussig shunt. Eight were newborn infants weighing 2.6 to 4.8 kg. All infants had complex congenital heart defects that were not considered amenable to early correction. There were no early deaths and no shunt failures. Postoperative complications were restricted to prolonged intubation in 2 patients and a subcutaneous wound infection in a 14-day-old infant. Follow-up from 1 to 31 months revealed minimal cyanosis, stable hemoglobin levels, and good shunt murmurs, and there have been no upper extremity complications. There were 2 late deaths; 1 (the oldest patient) was related to medication, and the second resulted from small bowel necrosis. The concept of the azygos vein patch modified Blalock-Taussig shunt involves two factors: (1) mobilizing as much length as possible of the subclavian artery in spite of its distal small size to allow for a tension-free shunt to prevent tension on the anastomosis as growth occurs, and (2) enlarging the subclavian artery distal to the vertebral artery origin with an autologous azygos patch. During performance of a standard Blalock-Taussig shunt, a longitudinal incision is made through the pulmonary artery across the anastomosis into the upper subclavian artery. The appropriate length of harvested azygos vein is used as a patch angioplasty across the shunt. A tension-free shunt with a patulous distal portion is achieved. Pulmonary overcirculation is avoided by the limiting size of the proximal subclavian artery. Temporary occlusion of the shunt at operation resulted in an increased mean blood pressure from 6 to 18% in all infants.(ABSTRACT TRUNCATED AT 250 WORDS)